The FDA has granted breakthrough therapy designation to furmonertinib for use as a potential therapeutic option in patients with previously untreated, locally advanced or metastatic nonsquamous non–small cell lung cancer harboring EGFR exon 20 insertion mutations.
Among women with breast cancer, sexual dysfunction often predates the cancer diagnosis and worsens in the following 2 years, according to an analysis of prospective data.
Most Women With Lung Cancer Report Sexual Dysfunction kxly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kxly.com Daily Mail and Mail on Sunday newspapers.
Most Women With Lung Cancer Report Sexual Dysfunction hazard-herald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hazard-herald.com Daily Mail and Mail on Sunday newspapers.